蘑菇AV

Aimed at teens and active users, this move could enhance personalization, increase engagement, and boost Meta鈥檚 ad appeal.

Claiming anticompetitive behavior, Google asks the FTC to break up the exclusive partnership, arguing that it locks rivals out and entrenches Azure鈥檚 dominance.

Google attracts EU scrutiny over advertising to teens: A global crackdown on privacy and teen data is extended to the search giant.

As social messaging takes off, marketers are trying to figure out how to show up within that context, whether through advertising, shareable posts, or customer service.

Department stores need a reboot after sales fell 1.6% last year: Retailers like Kohl鈥檚 are searching for a winning formula to revitalize the struggling department store model.

A scrappy Chinese startup disrupts the AI hierarchy with a lean, open-source model, challenging Big Tech鈥檚 costly infrastructure and rewriting the rules of AI competition.

This year, as the digital ad spend outpaces the time consumers are spending on the medium, media companies are leaning into revenue drivers like commerce media while also investing in content that builds community.

Could Trump鈥檚 second term include a ban on D2C pharma ads? We examine the likelihood of a ban and explore what more oversight of drug ads on TV means for pharma marketers.

Dr. Oz could be investigated for violating FTC influencer marketing guidelines: A consumer advocacy group triggered the investigation. We examine the complaints and explore what this scrutiny means for healthcare influencers.

Though most experienced drops in profit, big banks鈥� investment banking income helped them beat analysts鈥� expectations.

Capable new models and supercomputer plans show progress, but releasing a breakthrough 鈥渁ny-to-any鈥� model next year will test its execution under tight timelines

xAI鈥檚 plan for a standalone app may expand user access, but controversial outputs and app store policies could undermine its adoption and growth.

Walgreens鈥� biggest healthcare moves in 2024: Amid a brutal year trying and failing to achieve profitability, the company prioritized operating with a leaner business profile and is even considering a sale.

Trump鈥檚 first days in office exacerbate uncertainty over tariff plans: While Mexico and Canada are firmly in the administration鈥檚 sights, other tariffs are up in the air.

Steep discounts drove shoppers to spend on Cyber Monday: The Monday after Thanksgiving is poised to be the biggest online shopping day in US history.

Nextdoor q3 earnings highlight growth in ad revenues and active users: "Next" initiative drives platform evolution with focus on in-community connections.

Franchise Group is the latest retailer to file for bankruptcy: The parent company of banners that include Pet Supplies Plus and The Vitamin Shoppe plans to shutter its American Freight brand.

In the last 12 months cookies got a stay of execution, TikTok did not (yet), AI exploded, and viral content cluttered our feeds. So much happened in marketing in 2024, it can be difficult to cut through the noise and take stock of what to focus on in 2025.

Yum Brands uses AI to drive marketing for KFC, Taco Bell: The technology helps target audiences and write copy.

Shein, Temu, and Alibaba expand their US warehouse presence: The push dovetails with the US crackdown on the de minimis loophole.

Niche streaming services find foothold: Targeted platforms like Hallmark+ attract dedicated viewers amid competition from larger streamers.

鈥淪leepmaxxing鈥� is the newest health fad to go viral on TikTok: The social media-inspired trend entails using a range of products, services, and gadgets to optimize one鈥檚 sleep. But some ideas have gone too far and are potentially harmful.

Targeting bias detection and fostering global ties, the UK aims to lead in AI assurance and strengthen its tech sector.

Trump spent less on social media and won anyway: An established political brand and shifting social landscape reduced the need to lean on social platforms.

Activist investor takes $1B stake in Pfizer, eyes a performance turnaround: But to the drugmaker鈥檚 credit, its plan to diversify the therapeutic areas it will focus on moving forward should place it in line with investors鈥� expectations.